• ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspective
Weekly Newscast
dvm360 LIVE!™
Insights
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Client Handouts
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Coverage
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2022 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Elevated liver enzyme activity in a dog? An algorithm to help you determine Now what?

September 5, 2017
David Twedt, DVM, DACVIM

Whether a veterinary patient is symptomatic or asymptomatic, use this guide to help you get to a diagnosis.

You just got your laboratory report, which shows abnormal liver enzyme (e.g. alanine transaminase [ALT], aspartate aminotransferase [AST], gamma-glutamyltransferase [GGT] and alkaline phosphatase [ALP]) activity. The frustration begins. How much do you need to worry about it? The patient may have primary liver disease, but a nonhepatic condition resulting in secondary liver problems is more likely. It's important to find the exact cause, but the path to a diagnosis can be tricky to navigate-especially if the dog is asymptomatic.

Use the algorithm below as a guide for working up dogs with abnormal liver enzyme activities:

Click on the image to access a printable PDF.

If the patient is symptomatic:

When I have a sick dog with abnormal liver enzyme activities, the first thing I do is look for a primary, nonhepatic cause. Could it have gastrointestinal (GI) disease, pancreatitis, heart failure, septicemia or some other underlying disease?

If I identify a nonhepatic disease that could be the cause, I treat that first. If, on the other hand, I can't find anything, I work up the patient's liver.

Here's my list of liver workup considerations:

  • Abdominal radiographs

  • Serum bile acid concentration (in nonicteric patients)

  • Abdominal ultrasound

  • Hepatic fine-needle aspirate and cytology

  • Coagulation profile

  • Liver biopsy (via ultrasound-guided needle biopsy, surgery or laparoscopic biopsy).

 

If the patient is asymptomatic:

Determining what to do with an asymptomatic dog is more complex. First, I perform a full physical exam to make sure I'm not missing some occult disease, such as an endocrine or metabolic disease. I then check the patient's drug history, as certain drugs (such as corticosteroids) can cause liver changes. I also check to see whether the patient is being given alternative medications because some herbals can cause liver disease as well.

If I don't find anything and the animal's completely healthy, I repeat the liver enzyme profile in six to eight weeks. During this interim period, I may consider giving the patient liver support medications (like S-adenosylmethionine, milk thistle, vitamin E or other antioxidants) or a course of antibiotic therapy if I suspect a bacterial infection (such as leptospirosis or bacterial cholangitis).

If the liver enzyme activities are still abnormal and the patient is still asymptomatic at the end of this six- to eight-week waiting period, I recommend to the client that we need to further investigate the patient's liver.

One of the things I often do at this point is check the patient's bile acid concentration. If the patient has an abnormal bile concentration and abnormal liver enzyme activities, I have strong evidence for recommending a liver workup because it suggests there is altered liver function of portal vascular shunting.

 

Dr. David Twedt is a professor in the Department of Clinical Sciences at Colorado State University.

Related Content:

Clinical
Completing a neurological exam is like following a cooking recipe
Completing a neurological exam is like following a cooking recipe
Trends in canine oncology
Trends in canine oncology
Veterinary medicine in the military with Zachary Tooley
Veterinary medicine in the military with Zachary Tooley

Latest News

Veterinary scene Down Under: AI-driven pet advice app, plus Australia on alert for Indonesian livestock diseases and more

Pet Acoustics opens contest submissions for singing canines

Dr. Marty Pets announces new designs for its products

Brookfield Zoo welcomes South American tapir calf

View More Latest News